SCHEMBL14855136

SCHEMBL14855136

O=CN(Cc1ccccc1)C1CCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
G6PC1 P35575 1/20 0.49
ADH1A P07327 3/20 0.47
ADH1C P00326 2/20 0.47
AGER Q15109 3/20 0.44
MTNR1A P48039 1/20 0.44
USP2 O75604 1/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
MAPK1 P28482 1/20 0.42
SLC18A3 Q16572 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
ALOX12 P18054 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3238188 0.98 G6PC1 (0.51) G6PC1ADH1AADH1CAGERMTNR1A
SCHEMBL14855858 0.98 G6PC1 (0.51) G6PC1ADH1AADH1CAGERMTNR1A
SCHEMBL14855420 0.98 G6PC1 (0.46) G6PC1ADH1AADH1CAGERMTNR1A
SCHEMBL3240531 0.93 SLC6A2 (0.44) G6PC1ADH1AADH1CAGERMTNR1A
SCHEMBL19773700 0.88 G6PC1 (0.40) G6PC1ADH1AADH1CAGERMTNR1A
SCHEMBL8620642 0.85 SLC6A2 (0.56) G6PC1SLC6A2SLC6A4SLC6A3
SCHEMBL28169437 0.85 MEN1 (0.41) G6PC1AGERMTNR1ASLC6A2SLC6A4
SCHEMBL22813618 0.84 PKM (0.43) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL21985921 0.83 ALDH1A1 (0.39) G6PC1AGERMTNR1AUSP2HPGD
SCHEMBL1299875 0.81 ADH1A (0.53) G6PC1ADH1AADH1CUSP2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104926795-B Substituted heteroaryl compound and combinations thereof and purposes 广东东阳光药业有限公司 2017-11-10 CN disclosed
CN-104672250-B Substituted heteroaryl compound and combinations thereof and purposes 广东东阳光药业有限公司 2017-11-07 CN disclosed
CN-104974163-B Substituted heteroaryl compound and combinations thereof and purposes 广东东阳光药业有限公司 2017-11-07 CN disclosed
US-20130165446-A1 BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE HORIKOSHI, HIROYOSHI (CA) 2013-06-27 US disclosed
EP-2581373-A1 BENZO- OR PYRIDO-IMIDAZOLE DERIVATIVE Fujita, Takashi (JP) 2013-04-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165446-A1 BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE PPARG, PPARA, PPARD G6PC1 2696/4885ADH1A 1349/4885ADH1C 1360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.